Literature DB >> 21312248

Complex evaluation of ecotoxicity and genotoxicity of antimicrobials oxytetracycline and flumequine used in aquaculture.

Radka Zounková1, Zdeňka Klimešová, Leona Nepejchalová, Klára Hilscherová, Luděk Bláha.   

Abstract

Ecotoxicity and genotoxicity of widely used veterinary antimicrobials oxytetracycline and flumequine was studied with six model organisms (Vibrio fischeri, Pseudomonas putida, Pseudokirchneriella subcapitata, Lemna minor, Daphnia magna, Escherichia coli). Overall median effective concentration (EC50) values ranged from 0.22 mg/L to 86 mg/L. Pseudomonas putida was the most sensitive organism (EC50 values for 16-h growth inhibition were 0.22 and 0.82 mg/L for oxytetracycline and flumequine, respectively), followed by duckweed Lemna minor (7-d growth inhibition, EC50 2.1 and 3.0 mg/L) and green alga Pseudokirchneriella subcapitata (4-d growth inhibition, EC50 3.1 and 2.6 mg/L). The least sensitive organism was Daphnia magna (48-h immobilization, lowest-observed-effect concentration [LOEC] of oxytetracycline of 400 mg/L). Oxytetracycline showed limited genotoxicity (SOS-chromotest with Escherichia coli, minimal genotoxic concentration of 500 mg/L), and flumequine was genotoxic at 0.25 mg/L. Based on the reported measured concentrations (MECs) and predicted no-effect concentrations (PNECs), oxytetracycline may be concluded to be of ecotoxicological concern (calculated risk quotient = 8), whereas flumequine seems to represent lower risk.
Copyright © 2011 SETAC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21312248     DOI: 10.1002/etc.486

Source DB:  PubMed          Journal:  Environ Toxicol Chem        ISSN: 0730-7268            Impact factor:   3.742


  7 in total

Review 1.  Does the Recent Growth of Aquaculture Create Antibiotic Resistance Threats Different from those Associated with Land Animal Production in Agriculture?

Authors:  Hansa Y Done; Arjun K Venkatesan; Rolf U Halden
Journal:  AAPS J       Date:  2015-02-21       Impact factor: 4.009

Review 2.  Veterinary pharmaceuticals in aqueous systems and associated effects: an update.

Authors:  Samuel Obimakinde; Olalekan Fatoki; Beatrice Opeolu; Olatunde Olatunji
Journal:  Environ Sci Pollut Res Int       Date:  2016-10-18       Impact factor: 4.223

3.  Ecotoxicity of raw and treated effluents generated by a veterinary pharmaceutical company: a comparison of the sensitivities of different standardized tests.

Authors:  Bianca de S Maselli; Luis A V Luna; Joice de O Palmeira; Karla P Tavares; Sandro Barbosa; Luiz A Beijo; Gisela A Umbuzeiro; Fábio Kummrow
Journal:  Ecotoxicology       Date:  2015-02-15       Impact factor: 2.823

4.  Transferability of oxytetracycline (OTC) from feed to carp muscle and evaluation of the antibiotic effects on antioxidant systems in liver and kidney.

Authors:  Antonia Concetta Elia; Valentina Ciccotelli; Nicole Pacini; Ambrosius Josef Martin Dörr; Marilena Gili; Mauro Natali; Laura Gasco; Marino Prearo; Maria Cesarina Abete
Journal:  Fish Physiol Biochem       Date:  2014-01-05       Impact factor: 2.794

5.  Risk assessment of chlortetracycline, oxytetracycline, sulfamethazine, sulfathiazole, and erythromycin in aquatic environment: are the current environmental concentrations safe?

Authors:  Kyunghee Ji; Sunmi Kim; Sunyoung Han; Jihyun Seo; Sangwoo Lee; Yoonsuk Park; Kyunghee Choi; Young-Lim Kho; Pan-Gyi Kim; Jeongim Park; Kyungho Choi
Journal:  Ecotoxicology       Date:  2012-06-19       Impact factor: 2.823

6.  Effect of excessive doses of oxytetracycline on stress-related biomarker expression in coho salmon.

Authors:  Toshiki Nakano; Satoshi Hayashi; Norimi Nagamine
Journal:  Environ Sci Pollut Res Int       Date:  2015-06-26       Impact factor: 4.223

7.  Spatial overlap of shark nursery areas and the salmon farming industry influences the trophic ecology of Squalus acanthias on the southern coast of Chile.

Authors:  Juan Diego Gaitán-Espitia; Daniela Gómez; Alistair J Hobday; Ross Daley; Julio Lamilla; Leyla Cárdenas
Journal:  Ecol Evol       Date:  2017-04-18       Impact factor: 2.912

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.